vimarsana.com
Home
Live Updates
BrainVectis, a subsidiary of AskBio, receives clearance to c
BrainVectis, a subsidiary of AskBio, receives clearance to c
BrainVectis, a subsidiary of AskBio, receives clearance to conduct Phase I/II clinical trial in France for its novel gene therapy for early-stage Huntington's Disease
/PRNewswire/ -- Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, has received clearance to conduct...
Related Keywords
Paris ,
France General ,
France ,
North Carolina ,
United States ,
United Kingdom ,
Research Triangle Park ,
Edinburgh ,
City Of ,
French ,
Alexandra Durr ,
Sheila Mikhail ,
Nathalie Cartier Lacave ,
Bayer Ag ,
Linkedin ,
Reference Centre For Rare ,
National Agency For Safety Of Medicines ,
Health Products ,
Committee For Orphan Medicinal Products ,
European Union ,
Ethics Committee ,
Prnewswire Asklepios Biopharmaceutical Inc ,
European Medicines Agency ,
Asklepios Biopharmaceutical Inc ,
French Ethics Committee ,
National Agency ,
European Medicines ,
Vice President ,
Sector Lead Neurobiology ,
Orphan Medicinal Products ,
Professor Genetics ,
Preference Centre ,
Askbio ,